Therefore, it is imperative to identify a noninvasive surrogate biomarker that can alert people with or without T2DM to renal fibrosis, even in the absence of elevated serum creatinine, urine albumin, or altered eGFR. This evidence concerns the gene ALB and type 2 diabetes mellitus.